30 January 2023 - An analysis presented at the ISPOR Europe 2021 conference highlighted considerable variability across countries in how much pharmaceutical markups and taxes contributed to the total cost of pharmaceuticals.
From a sample of 35 countries and across 3 selected Anatomical Therapeutic Chemical categories (including A10S, L1G, and N3A), pharmaceutical markups and taxes contributed $8.6 billion (22.3%) and $2.4 billion (6.2%), respectively, to the $38.5 billion total expenditure in 2020.